{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreievvrz3faej7yvkwcdobsnvq3rbiphimyjdrmkppmifnf4xsnow2u",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mlxcxjnmfan2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie34fhn4oneakr55iwihbyhhw6huvqte43pshbpsgk7ihqdqlpqky"
    },
    "mimeType": "image/jpeg",
    "size": 39972
  },
  "path": "/2026/05/15/mifepristone-telehealth-abortion-alternatives-supreme-court/?utm_campaign=rss",
  "publishedAt": "2026-05-15T13:24:34.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "First Opinion",
    "abortion",
    "FDA",
    "legal",
    "Pharmaceuticals",
    "reproductive health"
  ],
  "textContent": "Restricting telehealth prescribing of mifepristone wouldn't spell the end of telehealth medication abortion, writes OB-GYN Christine Henneberg.",
  "title": "Opinion: Telehealth abortion with mifepristone continues, with backup plans still in place",
  "updatedAt": "2026-05-15T14:52:21.000Z"
}